Common Contracts
97 similar Collaboration and License Agreement contracts by Alnylam Pharmaceuticals, Inc., Lexicon Genetics Inc/Tx, Trubion Pharmaceuticals, Inc, others
REDACTED COPY COLLABORATION AND LICENSE AGREEMENT by and betweenCollaboration and License Agreement • October 5th, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
REDACTED COPY COLLABORATION AND LICENSE AGREEMENT by and betweenCollaboration and License Agreement • September 22nd, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
REDACTED COPY COLLABORATION AND LICENSE AGREEMENT by and betweenCollaboration and License Agreement • August 18th, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
BY AND AMONGCollaboration and License Agreement • August 4th, 2006 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WYETHCollaboration and License Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc • New York
Exhibit 10.5 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT dated as of March 17, 2006 by and between PTC THERAPEUTICS, INC.Collaboration and License Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • New York
INTRODUCTIONCollaboration and License Agreement • March 31st, 2006 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New York
EXHIBIT 10.39 AMENDMENT NO. 1 TO ADDENDUM RE: INFLUENZA PROGRAMCollaboration and License Agreement • March 16th, 2006 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations
BACKGROUNDCollaboration and License Agreement • November 14th, 2005 • SGX Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
RECITALSCollaboration and License Agreement • November 1st, 2005 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Texas
BY AND BETWEENCollaboration and License Agreement • September 12th, 2005 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
EXHIBIT 10.1 Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT THIS COLLABORATION AND LICENSE AGREEMENT (this "Agreement") is dated as of...Collaboration and License Agreement • July 29th, 2005 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
Exhibit 10.42 COLLABORATION AND LICENSE AGREEMENT THIS COLLABORATION AND LICENSE AGREEMENT (this "AGREEMENT") dated as of June 17, 2005, (the "EFFECTIVE DATE") is by and between Avalon Pharmaceuticals, Inc. ("AVALON"), a Delaware Corporation, having a...Collaboration and License Agreement • June 23rd, 2005 • Avalon Pharmaceuticals Inc • Pharmaceutical preparations • New York
ANDCollaboration and License Agreement • December 21st, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • New York
COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN MERCK & CO., INC. AND ALNYLAM PHARMACEUTICALS, INC.Collaboration and License Agreement • August 12th, 2004 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
EXHIBIT 10.15 Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • July 16th, 2004 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.24 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. STRATEGIC COLLABORATION AND LICENSE AGREEMENT This Strategic Collaboration and License Agreement (the...Collaboration and License Agreement • May 21st, 2004 • Alnylam Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EXECUTION COPY CONFIDENTIAL MATERIALS OMITTED AND FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • May 11th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
RECITALSCollaboration and License Agreement • April 29th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
RECITALSCollaboration and License Agreement • April 27th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
EXHIBIT 10.24 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. STRATEGIC COLLABORATION AND LICENSE AGREEMENT This Strategic Collaboration and License Agreement (the...Collaboration and License Agreement • April 6th, 2004 • Alnylam Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
INTRODUCTIONCollaboration and License Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New Jersey
EXHIBIT 10.15 Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 12th, 2004 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
EXECUTION COPY CONFIDENTIAL MATERIALS OMITTED AND FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 11th, 2004 • Momenta Pharmaceuticals Inc • New York
RECITALSCollaboration and License Agreement • January 27th, 2004 • Cytokinetics Inc • New York
INTRODUCTIONCollaboration and License Agreement • December 23rd, 2003 • Memory Pharmaceuticals Corp • New Jersey
INTRODUCTIONCollaboration and License Agreement • August 20th, 2003 • Nitromed Inc • Massachusetts
Exhibit 10.33 Portions of this exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of...Collaboration and License Agreement • August 14th, 2003 • Viropharma Inc • Pharmaceutical preparations • New Jersey
RECITALS:Collaboration and License Agreement • August 7th, 2003 • Introgen Therapeutics Inc • Pharmaceutical preparations • Texas
RECITALSCollaboration and License Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
RECITALSCollaboration and License Agreement • July 22nd, 2002 • Hyseq Inc • In vitro & in vivo diagnostic substances • California
Exhibit 10.1 D THIRD AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT Third amendment, dated March 25, 2002, (this "Amendment"), to the Collaboration and License Agreement and the Subscription Agreement dated June 12, 1998, each as amended through...Collaboration and License Agreement • May 9th, 2002 • Aphton Corp • Biological products, (no disgnostic substances) • New York
RECITALSCollaboration and License Agreement • April 1st, 2002 • Hyseq Inc • In vitro & in vivo diagnostic substances • California
CONFIDENTIAL MEDNOSTICS(TM) COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 7th, 2002 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
LETTERHEAD] SECOND AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT Second amendment, dated July 2nd, 2001, (this "Amendment"), to the Collaboration and License Agreement dated June 12, 1998, as amended through Amendment No. 1 to the Collaboration and...Collaboration and License Agreement • January 29th, 2002 • Aphton Corp • Biological products, (no disgnostic substances) • New York
